Bando H, et al. Therapeutic landscape and future direction of metastatic colorectal cancer. Nat Rev Gastroenterol Hepatol 2023; 20(5)306-322. doi:10.1038/s41575-022-00736-1. D'Haene N, et al. Clinical application of targeted next-generation sequencing for ...
1. Takeda Receives U.S. FDA Approval of FRUZAQLA™ (fruquintinib) for Previously Treated Metastatic Colorectal Cancer. Takeda. News release. November 8, 2023. Accessed November 9, 2023. 2. Shirley M. Fruquintinib: first global approval. Drugs. 2018;78(16):1757-1761. doi:10.1007...
Last updated: 13 November 2023You can legally access new medicines, even if they are not approved in your country. Learn how What is colorectal cancer? What are the types of colorectal cancer treatments available? What are new colon cancer treatments and how can I access them? Why access ...
improve safety and longevity, and reduce cost of goods sold and manufacturing complexities. Given that gene therapies usually have very high price tags, health-care systems across major markets will need to find a way to support access to these treatments. ...
We examined US drug approvals, given that most trials focus on the US and the FDA is typically the first regulatory agency to authorize new drugs [24]. Then, we limited the sample to anti-cancer treatments, excluding non-cancer drugs, supportive cancer agents, diagnostic medicines, and anti...
17.The human equivalent of this enzyme has been targeted in some cancer treatments as well as in immunosuppressive chemotherapies. Scientists at the University of Birmingham have now shown that inhibiting the same enzyme in M. tuberculosis effectively kills the bacterial cells.Laura Udakis...
Galena Moves Beyond Pain Relief to Targeted Cancer Treatments Rare Type of Leukemia Responds to Melanoma Treatment Vemurafenib Genetic Analysis of Remote Population May Advance Breast Cancer Prevention and Treatment Unprecedented Changes in Oncology: Toward a New DawnRelated...
[1,2]. Normal cell growth is controlled by stringent regulatory mechanisms; however, alterations in specific cell components can lead to dysfunction in these mechanisms, resulting in cancer [3]. Cancer treatments are tailored based on the type and stage of cancer, as well as the patient's ...
Table 3 2023 FDA orphan drug approvals. Percentage is that of orphan drugs within all drugs approved by the FDA in 2023 taken as 100% (https://www.accessdata.fda.gov/scripts/opdlisting/oopd/listResult.cfm) Full size table It is explicitly not our intention to compare novel treatments wit...
In 2023, Glaukos Corporation, a prominent company specializing in innovative treatments for glaucoma, corneal disorders and retinal diseases, achieved approval from the FDA for iDose TR (travoprost intracameral implant) 75 mcg, a prostaglandin analog designed for a single administration per eye. It ...